Clinical Trial Update: Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma. [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update of cetuximab with concomitant-boost accelerated radiotherapy for locally advanced oropharyngeal squamous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Trial Form Support S.L. | Conditions: Oropharyngeal Neoplasms | Phase 2 | Status: UNKNOWN